Tango Therapeutics, Inc.（TNGX）内部人交易：高管与董事近期交易
过去 18 个月，共有 15 位内部人为 Tango Therapeutics, Inc.（TNGX）报告了 72 笔 Form 4 交易（最近一笔 2026-10-05）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-05 | Crystal Adam | President, R&D | 卖出 | 26,400 | $645,604 |
| 2026-10-05 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-10-05 | Crystal Adam | President, R&D | 卖出 | 600 | $15,192 |
| 2026-09-24 | Newcomb Jessica | Principal Accounting Officer | 卖出 | 700 | $15,962 |
| 2026-09-24 | Newcomb Jessica | Principal Accounting Officer | 卖出 | 5,100 | $122,238 |
| 2026-09-24 | Newcomb Jessica | Principal Accounting Officer | 卖出 | 2,400 | $60,412 |
| 2026-09-03 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-09-03 | Crystal Adam | President, R&D | 卖出 | 27,000 | $603,909 |
| 2026-08-05 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-08-05 | Crystal Adam | President, R&D | 卖出 | 5,267 | $141,100 |
| 2026-08-05 | Crystal Adam | President, R&D | 卖出 | 21,733 | $594,417 |
| 2026-07-02 | Crystal Adam | President, R&D | 卖出 | 19,629 | $575,962 |
| 2026-07-02 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-07-02 | Crystal Adam | President, R&D | 卖出 | 7,371 | $222,946 |
| 2026-06-23 | Azelby Robert | 董事 | 买入 | 5,740 | $0 |
| 2026-06-08 | Ketchum John B | 董事 | 买入 | 4,000 | $0 |
| 2026-06-08 | Lee Sung | 董事 | 买入 | 570 | $0 |
| 2026-06-08 | Rothenberg Mace | 董事 | 买入 | 4,000 | $0 |
| 2026-06-08 | Calhoun Lesley Ann | 董事 | 买入 | 4,000 | $0 |
| 2026-06-03 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-06-03 | Crystal Adam | President, R&D | 卖出 | 6,140 | $136,615 |
| 2026-06-03 | Crystal Adam | President, R&D | 卖出 | 20,860 | $481,032 |
| 2026-05-05 | Crystal Adam | President, R&D | 卖出 | 1,100 | $24,200 |
| 2026-05-05 | Crystal Adam | President, R&D | 买入 | 27,000 | $140,400 |
| 2026-05-05 | Crystal Adam | President, R&D | 卖出 | 25,900 | $548,821 |
来源：SEC Form 4 申报文件 · 截至 2026-10-05